Page last updated: 2024-08-24

carbenoxolone sodium and Fatty Liver, Nonalcoholic

carbenoxolone sodium has been researched along with Fatty Liver, Nonalcoholic in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bae, GH; Jung, WH; Kim, CH; Kim, HY; Kim, KY; Kim, TJ; Park, JS; Park, SB; Rhee, SD	1

Other Studies

1 other study(ies) available for carbenoxolone sodium and Fatty Liver, Nonalcoholic

Article	Year
Carbenoxolone prevents the development of fatty liver in C57BL/6-Lep ob/ob mice via the inhibition of sterol regulatory element binding protein-1c activity and apoptosis. European journal of pharmacology, 2012, Sep-15, Volume: 691, Issue:1-3 Topics: Animals; Apoptosis; Carbenoxolone; Cytokines; Enzyme Inhibitors; Fatty Acids, Nonesterified; Fatty Liver; Gene Expression Regulation; Hep G2 Cells; Humans; Lipogenesis; Liver; Male; Mice; Mice, Inbred C57BL; Mitochondria; Non-alcoholic Fatty Liver Disease; Reactive Oxygen Species; Sterol Regulatory Element Binding Protein 1; Triglycerides	2012

Article

Year

Carbenoxolone prevents the development of fatty liver in C57BL/6-Lep ob/ob mice via the inhibition of sterol regulatory element binding protein-1c activity and apoptosis.

European journal of pharmacology, 2012, Sep-15, Volume: 691, Issue:1-3

Topics: Animals; Apoptosis; Carbenoxolone; Cytokines; Enzyme Inhibitors; Fatty Acids, Nonesterified; Fatty Liver; Gene Expression Regulation; Hep G2 Cells; Humans; Lipogenesis; Liver; Male; Mice; Mice, Inbred C57BL; Mitochondria; Non-alcoholic Fatty Liver Disease; Reactive Oxygen Species; Sterol Regulatory Element Binding Protein 1; Triglycerides

2012